Fludaphos 50mg Injection
Marketer
Bharat Serums & Vaccines Ltd
Salt Composition
Fludarabine (50mg)
Overview Fludaphos 50mg Injection
Fladaphos 50mg injection treats chronic lymphocytic leukemia (CLL), a type of blood cancer. Its application may extend to other conditions at your physician's discretion, possibly as part of a combined chemotherapy regimen. Administered intravenously under medical supervision, the dosage and frequency are determined by your doctor based on your specific needs and may vary. Strict adherence to the prescribed regimen is crucial; misuse or overdose can lead to severe complications. Therapeutic benefits may take weeks or months to manifest; discontinue use only as directed by your doctor. Common side effects include nausea, vomiting, diarrhea, headache, fatigue, fever, and cough. A reduction in blood cell counts (white and red blood cells), increasing infection risk, is possible. Regular blood tests monitoring blood cell counts, along with heart, liver, and uric acid levels, are necessary. Inform your doctor of any pre-existing heart, liver, or kidney conditions, or concurrent use of infection-fighting medications. Interactions with other drugs are possible; disclose all medications. This medication is contraindicated during pregnancy and breastfeeding. Reliable contraception is essential for both partners throughout the treatment period to prevent pregnancy.
Primary Ingredients of Fludaphos 50mg Injection
The provided information is insufficient.
Uses of Fludaphos 50mg Injection
Chronic lymphocytic leukemia, a type of blood malignancy
Major Benefits of Fludaphos 50mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Fludaphos 50mg Injection:
- Increased risk of infection
- Vomiting
- Weakness
- Nausea
- Fatigue
- Fever
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Cough
How to use Fludaphos 50mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Fludaphos 50mg Injection works:
The injectable anticancer drug Fludaphos 50mg disrupts the DNA and RNA replication within cancerous blood cells, thus inhibiting their proliferation and ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Fludaphos 50mg Injection may pose safety risks; physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Fludaphos 50mg Injection during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Fludaphos 50mg Injection while breastfeeding is contraindicated due to potential infant toxicity indicated by available data.
DrivingUNSAFE
Administering Fludaphos 50mg Injection may induce adverse reactions impacting driving capabilities. Fatigue, weakness, visual disturbances, confusion, agitation, or seizures have been reported in some patients receiving Fludaphos 50mg Injection, potentially compromising safe driving.
KidneyCAUTION
Administering Fludaphos 50mg Injection to individuals with impaired renal function requires careful consideration. A modified dosage of Fludaphos 50mg Injection might be necessary. Physician consultation is advised. Fludaphos 50mg Injection is contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
For individuals with hepatic impairment, administering Fludaphos 50mg Injection requires careful consideration. Dosage modification of Fludaphos 50mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Fludaphos 50mg Injection :
NA
Facts to Know About Fludaphos 50mg Injection
| Label | Value |
|---|---|
| Type of Compound | Synthetic purine nucleoside analogs |
| Potential for Dependence | None. |
| Type of Treatment | Cancer treatments |
| Mechanism of Action | Metabolic antagonists |
3,018 People bought this recently